Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 7
1985 2
1986 8
1987 9
1988 26
1989 31
1990 25
1991 16
1992 32
1993 14
1994 14
1995 13
1996 9
1997 9
1998 8
1999 10
2000 6
2001 7
2002 1
2004 2
2005 4
2006 4
2007 1
2008 1
2009 4
2011 1
2012 2
2013 2
2014 2
2015 3
2017 1
2019 1
2020 1
2021 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Results by year

Filters applied: . Clear all
Page 1
Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB, Brogden RN. Barradell LB, et al. Drugs. 1992 Nov;44(5):800-34. doi: 10.2165/00003495-199244050-00008. Drugs. 1992. PMID: 1280568 Review.
Cefodizime is a third generation cephalosporin with a broad spectrum of antibacterial activity. ...While there are no trials comparing cefodizime to other third generation cephalosporins in immunosuppressed populations, preliminary information indicates cefodizim …
Cefodizime is a third generation cephalosporin with a broad spectrum of antibacterial activity. ...While there are no trials comparin …
Pharmacokinetics of cefodizime: a review of the data on file.
Barré J. Barré J. J Antimicrob Chemother. 1990 Nov;26 Suppl C:95-101. doi: 10.1093/jac/26.suppl_c.95. J Antimicrob Chemother. 1990. PMID: 2074258 Review.
Cefodizime is a new aminothiazolyl cephalosporin which may be administered iv or im. ...The mean volume of distribution is approximately 6.2-8.51. Protein binding of cefodizime is 73-89% over the plasma concentration range. Cefodizime penetrates into several …
Cefodizime is a new aminothiazolyl cephalosporin which may be administered iv or im. ...The mean volume of distribution is approximat …
The in-vitro activity of cefodizime: a review.
Soussy CJ, Chanal M, Kitzis MD. Soussy CJ, et al. J Antimicrob Chemother. 1990 Nov;26 Suppl C:13-21. doi: 10.1093/jac/26.suppl_c.13. J Antimicrob Chemother. 1990. PMID: 2074248 Review.
Cefodizime was noticeably less active against Pseudomonas aeruginosa and Acinetobacter baumannii with MICs ranging from 32 to more than 128 mg/l. ...A fairly wide range of MICs was found for anaerobes, with lower values for Clostridium perfringens (MIC50 and MIC90 0.5 and …
Cefodizime was noticeably less active against Pseudomonas aeruginosa and Acinetobacter baumannii with MICs ranging from 32 to more th …
[Neisseria gonorrhoeae infections].
Furuya R, Tanaka M. Furuya R, et al. Nihon Rinsho. 2009 Jan;67(1):129-35. Nihon Rinsho. 2009. PMID: 19177762 Review. Japanese.
So, as first-line therapy for gonococcal infections, only three parenteral regimens of single doses of ceftriaxone, cefodizime or spectinomycin are recommended by the Japanese Society for Sexually Transmitted Diseases. ...
So, as first-line therapy for gonococcal infections, only three parenteral regimens of single doses of ceftriaxone, cefodizime or spe …
Immunomodulating effects of antibiotics: literature review.
Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, Ringoir S. Van Vlem B, et al. Infection. 1996 Jul-Aug;24(4):275-91. doi: 10.1007/BF01743360. Infection. 1996. PMID: 8875279 Review.
Concerning phagocytosis, positive effects were observed for cefodizime, imipenem, cefoxitin, amphotericin B and clindamycin and negative effects for erythromycin, roxithromycin, cefotaxime, tetracycline, ampicillin and gentamicin. ...Erythromycin and amphotericin B appear …
Concerning phagocytosis, positive effects were observed for cefodizime, imipenem, cefoxitin, amphotericin B and clindamycin and negat …
[Cefodizime].
Matsumoto K. Matsumoto K. Jpn J Antibiot. 1991 Mar;44(3):249-63. Jpn J Antibiot. 1991. PMID: 1880907 Review. Japanese. No abstract available.
Pharmacokinetic profile of cefodizime.
Brockmeier D, Dagrosa EE. Brockmeier D, et al. Infection. 1992;20 Suppl 1:S14-7. doi: 10.1007/BF01709944. Infection. 1992. PMID: 1526669 Review.
The pharmacokinetics of cefodizime (CDZ) were determined after i.v. and i.m. administration of single doses of up to 2 g and after i.v. administration of 2 g b.i.d. for six days. ...In urine, therapeutic concentrations were present for more than 24 h after administration o …
The pharmacokinetics of cefodizime (CDZ) were determined after i.v. and i.m. administration of single doses of up to 2 g and after i. …
Cefodizime in clinical use: a review of the clinical trial reports.
Grassi GG. Grassi GG. J Antimicrob Chemother. 1990 Nov;26 Suppl C:117-25. doi: 10.1093/jac/26.suppl_c.117. J Antimicrob Chemother. 1990. PMID: 2074246 Review.
The clinical efficacy of cefodizime has been tested in several open and comparative studies, above all in lower respiratory tract infections (LRTI) and uncomplicated urinary tract infections (UTI), performed in 151 centres in Europe, Latin America, South-Eastern Asia and S …
The clinical efficacy of cefodizime has been tested in several open and comparative studies, above all in lower respiratory tract inf …
Antibiotics as biological response modifiers.
Ritts RE. Ritts RE. J Antimicrob Chemother. 1990 Nov;26 Suppl C:31-6. doi: 10.1093/jac/26.suppl_c.31. J Antimicrob Chemother. 1990. PMID: 2074250 Review.
The classic example of polymyxin as an immunomodulating, albeit toxic, antibiotic offers a rational and definitive basis for the concept. In-vitro data on cefodizime, a third generation cephalosporin that achieves good tissue levels, are presented and show the ability of t …
The classic example of polymyxin as an immunomodulating, albeit toxic, antibiotic offers a rational and definitive basis for the concept. In …
Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties.
Labro MT. Labro MT. J Antimicrob Chemother. 1990 Nov;26 Suppl C:37-47. doi: 10.1093/jac/26.suppl_c.37. J Antimicrob Chemother. 1990. PMID: 2074251 Review.
Immunomodulation by antibacterial agents shows promise as a novel strategy in the treatment of infectious diseases. Cefodizime, a new oxi-imino-amino-2-thiazolyl cephalosporin, is a particularly good candidate in this context. ...To date, the mechanisms underlying the immu …
Immunomodulation by antibacterial agents shows promise as a novel strategy in the treatment of infectious diseases. Cefodizime, a new …
281 results